New Accelerator Seeks to Attract Connected Health and Fitness Startups from Across the Country to Baltimore
Wednesday, July 12, 2017
The 16-week M-1 Ventures program to provide dedicated startup support that facilitates the development of innovative health care solutions
Johns Hopkins Technology Ventures, Plank Industries, the University of Maryland (through UM Ventures), Brown Advisory and the Abell Foundation announced today that they are providing support for M-1 Ventures, a new Baltimore-based startup accelerator focused on connected health and fitness technologies. The 16-week program will be housed in FastForward East, an innovation hub on the Johns Hopkins medical campus, and will challenge startups selected from a national applicant pool to validate their business models, engage with customers and build on traction they have already generated. Additional support for the program comes from the Maryland Department of Commerce and Village Capital.
“By focusing this accelerator on connected health and fitness, M-1 Ventures takes advantage of our regional strengths to provide startups in this business vertical with a clearer path to success,” says Christy Wyskiel, a senior adviser to the president of The Johns Hopkins University and leader of Johns Hopkins Technology Ventures. “M-1 participants will receive specialized support and resources from top industry researchers, entrepreneurs and innovators that will help them develop health and fitness solutions that will drive real impact.”
The program will run under the direction of Paul Singh, an entrepreneur, angel investor and co-founder of the investment firm 500 Startups, and former Wells Fargo, UBS and Bank of America executive Tony D’Agostino, a serial entrepreneur currently working with ZyGood, a medical device startup developing an external neuromodulation device to treat chronic pain. Experts from The Johns Hopkins University, Plank Industries, the University of Maryland, Brown Advisory and several other dedicated, experienced mentors will provide guidance to the M-1 entrepreneurs.
Click here to read the rest of the story via Johns Hopkins Medicine website